[go: up one dir, main page]

AR026026A1 - Compuesto de taxano pentaciclico. - Google Patents

Compuesto de taxano pentaciclico.

Info

Publication number
AR026026A1
AR026026A1 ARP000105381A ARP000105381A AR026026A1 AR 026026 A1 AR026026 A1 AR 026026A1 AR P000105381 A ARP000105381 A AR P000105381A AR P000105381 A ARP000105381 A AR P000105381A AR 026026 A1 AR026026 A1 AR 026026A1
Authority
AR
Argentina
Prior art keywords
action
pentaciclic
taxan
compound
antitumor
Prior art date
Application number
ARP000105381A
Other languages
English (en)
Inventor
Tsunehiko Soga
Yasuyuki Takeda
Kouichi Uoto
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of AR026026A1 publication Critical patent/AR026026A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Un nuevo derivado de taxol que tiene grupos sustituyentes respectivos, representado por la siguiente formula 1, que puede darse oralmente y que tiene unaactuacion antitumoral. Los valores de los sustituyentes de esta formula pueden ser consultados enla descripcion. Se sabe que el taxol es una sustancia de unaactuacion antitumoral considerándose que su mecanismo de actuacion se funda en su funcion inhibitoria de la despolimerizacion de microtubulos en la divisioncelular, y se espera que su aplicacion clínica sea debida a un mecanismo de accion diferente de los agentes antitumorales convencionales.
ARP000105381A 1999-10-15 2000-10-13 Compuesto de taxano pentaciclico. AR026026A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29335699 1999-10-15

Publications (1)

Publication Number Publication Date
AR026026A1 true AR026026A1 (es) 2002-12-26

Family

ID=17793741

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105381A AR026026A1 (es) 1999-10-15 2000-10-13 Compuesto de taxano pentaciclico.

Country Status (22)

Country Link
EP (1) EP1221445B1 (es)
JP (1) JP3776799B2 (es)
KR (1) KR100706566B1 (es)
CN (1) CN1203074C (es)
AR (1) AR026026A1 (es)
AT (1) ATE405569T1 (es)
AU (1) AU774787B2 (es)
BR (1) BR0014687A (es)
CA (1) CA2386772C (es)
DE (1) DE60039998D1 (es)
DK (1) DK1221445T3 (es)
ES (1) ES2311473T3 (es)
HK (1) HK1044000B (es)
IL (2) IL149007A0 (es)
MX (1) MXPA02003797A (es)
MY (1) MY125378A (es)
NO (1) NO328418B1 (es)
PT (1) PT1221445E (es)
RU (1) RU2257387C2 (es)
TW (1) TWI225062B (es)
WO (1) WO2001027115A1 (es)
ZA (1) ZA200202696B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04005192A (es) * 2001-11-29 2005-02-22 Daiichi Seiyaku Co Cristal de derivado de taxano y metodo para preparar el mismo.
TW200533339A (en) 2004-03-16 2005-10-16 Bristol Myers Squibb Co Therapeutic synergy of anti-cancer compounds
MXPA06012588A (es) * 2004-04-30 2007-01-31 Daiichi Seiyaku Co Proceso para producir taxano pentaciclico.
US20090186868A1 (en) * 2005-10-25 2009-07-23 Daiichi Sankyo Company Limited Taxane Compound Having Azetidine Ring Structure
CN100516067C (zh) * 2006-01-10 2009-07-22 上海恒瑞医药有限公司 具有抗肿瘤活性的紫杉酚衍生物
US8785669B2 (en) 2010-06-30 2014-07-22 Gfv, Llc Taxane compounds, compositions and methods
KR20140056238A (ko) 2011-08-02 2014-05-09 아스텔라스세이야쿠 가부시키가이샤 약제의 병용에 의한 암 치료 방법
FR2986526A1 (fr) 2012-02-03 2013-08-09 Sanofi Sa Procede de preparation de derives du taxol et certains composes intermediaires
CN104650109B (zh) * 2013-11-22 2019-01-01 江苏天士力帝益药业有限公司 紫杉烷类化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
FR2698871B1 (fr) * 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
FR2712289B1 (fr) * 1993-11-08 1996-01-05 Rhone Poulenc Rorer Sa Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent.
DE69615016T2 (de) * 1995-04-28 2002-05-02 Daiichi Pharmaceutical Co., Ltd. Pentacyclische verbindungen
TW527183B (en) * 1996-06-06 2003-04-11 Daiichi Seiyaku Co Drug complex

Also Published As

Publication number Publication date
JP3776799B2 (ja) 2006-05-17
CN1203074C (zh) 2005-05-25
HK1044000A1 (en) 2002-10-04
BR0014687A (pt) 2002-11-19
DK1221445T3 (da) 2008-11-24
TWI225062B (en) 2004-12-11
MY125378A (en) 2006-07-31
ES2311473T3 (es) 2009-02-16
IL149007A (en) 2006-12-10
ATE405569T1 (de) 2008-09-15
ZA200202696B (en) 2003-09-23
AU7685100A (en) 2001-04-23
AU774787B2 (en) 2004-07-08
WO2001027115A1 (en) 2001-04-19
CA2386772C (en) 2009-01-13
NO20021753L (no) 2002-06-12
IL149007A0 (en) 2002-11-10
NO328418B1 (no) 2010-02-15
EP1221445B1 (en) 2008-08-20
MXPA02003797A (es) 2002-12-13
RU2257387C2 (ru) 2005-07-27
KR100706566B1 (ko) 2007-04-13
KR20020035901A (ko) 2002-05-15
NO20021753D0 (no) 2002-04-12
CA2386772A1 (en) 2001-04-19
EP1221445A1 (en) 2002-07-10
HK1044000B (en) 2008-11-21
CN1409714A (zh) 2003-04-09
DE60039998D1 (de) 2008-10-02
EP1221445A4 (en) 2003-05-28
PT1221445E (pt) 2008-10-08

Similar Documents

Publication Publication Date Title
NO20050065L (no) Kjemiske forbindelser
MY136789A (en) Metalloproteinase inhibitors
MA27899A1 (fr) Compose de glucocorticosteroide specifique a activite anti-inflammatoire
NO20052887L (no) Pyridazinonderivater som GSK-3Beta inhibitorer.
TR200101906T2 (tr) Antiviral ajanlar olarak kuinolinkarboksamitler
ATE449099T1 (de) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
NO20052884L (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
NO20014756L (no) C(10)-heterosubstituerte acetattaxaner som antitmormidler
PE20020747A1 (es) Taxanos de carbonato c-4 oralmente activos
AR026026A1 (es) Compuesto de taxano pentaciclico.
ATE498669T1 (de) 2,6-naphthylreste enthaltende verbindungen
DOP2006000045A (es) Derivados del (1,5-difenil-1h-pirazol-3-il oxadiazol, su preparacion y su aplicacion en terapeutica
HRP20080529T3 (en) Amide prodrug of gemcitabine, compositions and use thereof
SE0103710D0 (sv) Compounds
DE60316984D1 (de) Benzoylsulfonamide als antitumor-mittel
DE69834271D1 (de) Steroid-3-o-sulfamat-derivate als estronsulfatase-hemmer
PA8437201A1 (es) Compuestos de pirrolidinil y pirrolinil etilamina como agonistas kappa.
NO20050871L (no) 6-amino-1H-indazol- og 4-aminobenzofuranforbindelser som fosfodiesterase 4-inhibitorer
CO5011097A1 (es) Derivados de 8-azabiciclo [3.2.1]octan-3-metanamina .
NO20014758D0 (no) C(7)-heterosubstituerte acetattaksaner som antitumormidler
DK1658062T3 (da) Alfa-aminoamid-derivater anvendelige som anti-inflammatoriske midler
ATE399169T1 (de) Imidazopyridinderivate als inhibitoren der induzierbaren no-synthase
ATE403655T1 (de) Imidazopyridinderivate als induzierbare no- synthaseinhibitoren
NO20014754D0 (no) C(10)-estersubstituerte taksaner som antitumormidler
ATE398617T1 (de) Imidazoä4,5-büpyridinderivate als inhibitoren der induzierbaren no-synthase

Legal Events

Date Code Title Description
FG Grant, registration